Kajian DRPs dan pola peresepan pada pasien rawat inap anak dengan asma

Authors

  • Dyah Anggraeni Budhi Pratiwi Sekolah Tinggi Ilmu Kesehatan Surya Global, Indonesia
  • Novita Anggraini Sekolah Tinggi Ilmu Kesehatan Surya Global
  • Nur Aeni Sekolah Tinggi Ilmu Kesehatan Surya Global

DOI:

https://doi.org/10.32504/hspj.v6i1.543

Keywords:

Asthma, children, drug-related problems, drug use patterns

Abstract

The incidence of drug-related problems (DRPs) is very common occur in pediatric inpatients where treatment must be prioritized because their physiological conditions are not yet perfect so metabolism and drug absorption cannot be equated. The risk of developing DRPs results in a decrease in the patient's quality of life, increases the rate of death and disability and increases costs. Asthma is a chronic disease, the prevalence of asthma in children is high enough that it requires serious attention. In Indonesia, the prevalence of asthma in elementary school children (0-14 years) is 9.6%. This study aims to identify drug related problems and determine treatment patterns in pediatric patients with asthma at X Hospital. This research was a non-experimental study conducted with a descriptive design through retrospective data retrieval of the medical records of children with asthma who were hospitalized in January-July 2017 at X hospital. DRPs and treatment patterns were assessed from the patient's medical record data and then analyzed using percentages. DRPs were entered in bullet points while treatment patterns were in the table. The results of this study were the class of drugs used. Corticosteroids, beta-2 agonists, beta-2 agonists and anticholinergic combinations, beta-2 agonist combinations with corticosteroids, antihistamines, antihistamine and decongestant combinations and methylxanthine. Types of drugs used are salbutamol, procaterol, dexamethasone, methylprednisolone, triamcinolone, budesonide, aminophylline, and a combination of albuterol and ipratropium bromide. The results of the DRPs study were, that there was no indication that there was no treatment, drugs with inappropriate indications in 50%, the wrong drug was 66.6%, the dose was too high at 61.1%, drug interactions amounted to 22.2%, and non-compliance does not exist.

 

Author Biographies

Dyah Anggraeni Budhi Pratiwi, Sekolah Tinggi Ilmu Kesehatan Surya Global

Program Studi Farmasi

Novita Anggraini, Sekolah Tinggi Ilmu Kesehatan Surya Global

Program Studi Farmasi

Nur Aeni, Sekolah Tinggi Ilmu Kesehatan Surya Global

Program Studi Farmasi

References

WHO. Asthma [Internet]. 2022. Available from:

https://www.who.int/news-room/fact sheets/detail/asthma

Asthma GIF. GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf. 2022. p. 225.

RI KK, Asthma GIF. Laporan Nasional RISKESDAS 2018. 2018.

UKK Rerpirologi PP IDAI. Pedoman Nasional Anak Asma. Pedoman Nas Asma Anak. 2016;2:80.

SAMUEL S. ALLEMANN, J. W. FOPPE VAN MIL LB. Pharmaceutical Care- the PCNE definition 2013. Int J Clin Prahmacy [Internet]. 2014;36:544–555. Available from:

https://www.pcne.org/upload/files/9_20140430_PCNE_Definition_IJCP_POSTPRINT.pdf

Cipolle RJ, Strand LM MP. Pharmaceutical Care Practice : The Clinician’s Guide, 2nd ed. McGraw-Hill Companies; 2004.

Cohen M. Medication Errors. The American Pharmaceutical Association. Washington. USA; 1999.

Floriddia D. Management of Medication Errors. 1999.

Anggareni D, Ikawati Z, Kusharwanti W. Kajian Drug Related Problems pada Pasien Anak dengan Infeksi Saluran Nafas Bawah dan Asma di Rumah Sakit Panti Rapih Yogyakarta Periode 1 Januari 2006 – 30 Juni 2006. J Manag Pharm Pract. 2011;1(4):262–8.

Desti A. Evaluasi Drug Related Problems (DRPs) Pada Pasien Anak Dengan Asma Di Instalasi Rawat Inap RS RK Charitas Palembang Periode Juli-Desember 2013. 2013.

Wahyudi A, Fitry Yani F, Erkadius E. Hubungan Faktor Risiko terhadap Kejadian Asma pada Anak di RSUP Dr. M. Djamil Padang. J Kesehat Andalas. 2016;5(2):312–8.

Suyono S. Buku Ajar Ilmu Penyakit Dalam Jilid II Edisi 3. 3rd ed. Jakarta: Balai Penerbit FKUI; 2001.

Yosmar R, Andani M, Arifin H. Study on Dosage Regimens of Asthma Medications in Pediatric Patients of Dr. M. Djamil Padang Hospital. J Sains Farm Klin [Internet]. 2015;2(1):22–9. Available from:

http://jsfkonline.org/index.php/jsfk/article/view/48

Nasution WK. Evaluasi Penggunaan Obat Asma Pada Pasien Asma di Instalasi Rawat Jalan Rumah Sakit Umum Pusat H. Adam Malik Medan. Univ Sumatera Utara. 2018;

(PDPI) PDPI. ASMA Pedoman Diagnosa & Penatalaksanaan DI Indonesia. Perhimpunan Dokter Paru Indonesia; 2016.

Wibowo SA. Kajian Profil Peresepan Pasien Asma Bronkial Di Instalasi Rawat Inap Rumah Sakit Umum Daerah Bangli-Bali Tahun 2005. 2007;

Ikawati Z. Penyakit Sistem Pernafasan Dan Tatalaksana Terapinya. Yogyakarta: Bursa Ilmu; 2011.

aberg J.A, Lacy C, Amstrong L, Goldman M, Lance LL. drug informastion handbook 21th Edition. Vol. 21. Ohio: american Pharmacist Association; 2012.

Preston, Claire L. Stockley’s Drug Interactions 12th. the Royal Pharmaceutical Society of Great Britain, London; 2019.

Hansten P. Drug interaction management. Phamacy World Sci. 2003;25:94–7.

Downloads

Published

2022-08-22

Issue

Section

Articles

Citation Check